slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
0,013 USD | +6.400,00% | +8,33% | -89,47% |
10/04 | Sorrento Therapeutics, Inc. Uit faillissement gekomen | CI |
15/03 | Scilex schikt vorderingen in zaak tegen Virpax voor $6 miljoen, 6% royalty's van drie geneesmiddelen | MT |
Omzet 2021 | 52,9 mln. 48,71 mln. | Omzet 2022 | 62,84 mln. 57,86 mln. | Marktkapitalisatie | 411 mln. 379 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2021 | -428 mln. -394 mln. | Nettowinst (verlies) 2022 | -573 mln. -528 mln. | EV/omzet 2021 | 29,1 x |
Nettoschuld 2021 | 111 mln. 102 mln. | Nettoschuld 2022 | 84,53 mln. 77,82 mln. | EV/omzet 2022 | 7,89 x |
K/w-verhouding 2021 |
-3,2
x | K/w-verhouding 2022 |
-0,65
x | Werknemers | 949 |
Dividendrendement 2021 * |
-
| Dividendrendement 2022 |
-
| Vrij verhandelbaar | 97,77% |
1 dag | +6.400,00% | ||
1 week | +8,33% | ||
Lopende maand | -18,75% | ||
1 maand | -35,00% | ||
3 maanden | -58,06% | ||
6 maanden | -74,00% | ||
Lopend jaar | -89,47% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Henry Ji
CEO | Chief Executive Officer | 59 | 01-01-89 |
Shawn Sahebi
COO | Chief Operating Officer | - | - |
Mike A. Royal
CTO | Chief Tech/Sci/R&D Officer | 70 | 03-03-14 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Kim D. Janda
BRD | Director/Board Member | 67 | 01-04-12 |
David Lemus
BRD | Director/Board Member | 61 | 01-10-17 |
Jaisim Shah
BRD | Director/Board Member | 63 | 11-09-13 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.03% | 1 487 M€ | +9,49% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
20-05-24 | 0,013 | +6.400,00% | 68 939 |
17-05-24 | 0,0002 | -98,33% | 115 821 |
16-05-24 | 0,012 | -7,69% | 50 515 |
15-05-24 | 0,013 | -3,70% | 122 468 |
14-05-24 | 0,0135 | +12,50% | 60 535 |
slotkoers OTC Markets, 20 mei 2024
Meer koersenVaira. 1 jan. | Kapi. | |
---|---|---|
-89,47% | 7,07 mln. | |
+9,58% | 115 mld. | |
+12,41% | 107 mld. | |
-3,41% | 21,6 mld. | |
-12,38% | 22,31 mld. | |
-5,29% | 19,19 mld. | |
-3,35% | 18,23 mld. | |
-38,57% | 17,62 mld. | |
+7,51% | 14,26 mld. | |
+35,67% | 12,37 mld. |